Assistant Professor/Associate Professor, General Oncology - Internal Medicine, McGovern Medical School jobs in United States
cer-icon
Apply on Employer Site
company-logo

UTHealth Houston · 1 month ago

Assistant Professor/Associate Professor, General Oncology - Internal Medicine, McGovern Medical School

positionTexas, United States
timeFull-time
remoteOnsite
seniorityMid, Senior Level

UTHealth Houston is seeking an Assistant or Associate Professor in General Oncology to join the Division of Oncology. The role involves building a clinical program, providing inpatient and outpatient care, teaching, and engaging in clinical research in collaboration with the University of Texas faculty and Memorial Hermann Cancer Centers.

EducationHealth CareProfessional Services
check
H1B Sponsor Likelynote

Responsibilities

Building a robust clinical program in collaboration with the University of Texas faculty and Memorial Hermann Cancer Centers
Involves inpatient and outpatient clinical care, teaching, education, and clinical research that aligns with the mission of McGovern Medical School and UTHealth Houston

Qualification

Board-certified in oncologyHematology certificationClinical trainingTreatment modalities experience

Required

Board-certified or eligible in oncology and hematology
Strong clinical training and experience in all current treatment modalities

Company

UTHealth Houston

twittertwittertwitter
company-logo
UTHealth Houston provides resources for health care education, innovation, and scientific discovery.
dateFounded in 1972
location
Houston, Texas, USA
people-size1001-5000 employees
web-link
https://www.uth.edu

H1B Sponsorship

UTHealth Houston has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (156)
2024 (133)
2023 (83)
2022 (111)
2021 (64)
2020 (64)

Funding

Current Stage
Late Stage
Total Funding
$28.6M
Key Investors
National Institute of Neurological Disorders and StrokeNational Cancer InstituteCDMRP
2024-10-09Grant· $2.5M
2024-10-08Grant· $4.8M
2023-11-09Grant· $5M

Leadership Team

leader-logo
Michael Tramonte
Senior Vice President, Chief Financial Officer
linkedin
leader-logo
Melissa Pifko
Senior Vice President and Chief Legal Officer
linkedin

Recent News

Steadman Philippon Research Institute
NIH-Funded Study Launches at SPRI to Advance Shoulder Repair Techniques
2025-09-17
vcnewsdaily.com
EndoQuest Robotics Bags Series D-2 Funding
2025-07-15
EIN Presswire
New Study Reveals How RUNX2 Regulates Skull Development
2025-06-23
Company data provided by crunchbase